Intestinal trefoil factors and nucleic acids encoding intestinal trefoil
factors are disclosed. The intestinal trefoil factors disclosed are
resistant to destruction in the digestive tract and can be used for the
treatment of peptic ulcer diseases, inflammatory bowel diseases, eye
disorders and other insults.